Merck: Mirena: highlights of prescribing information. 2015. Available at: http://labeling.bayerhealthcare.com/h tmIl products/pi/Mirena_PI. pdf. Accessed October 11, 2016
Merck: Nexplanon: highlights of prescribing information. 2016a. Available at: https:llwww.merck.com/product/usa/pi_circulars/n/nexplanon/nexplanon_pi.pd. Accessed December 27,n2016
Merck: NuvaRing: prescribing information. 2016b. Available at: https:llwww. merck.com/product/usa/pi_circulars/n/nuvaring/nuvarin�pi.pdf. Accessed December 27,n2016
Minnis MI, Padian NS: Efectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions. Sex Transm Infect 81(3):193, 2005 \lody SK, Kileyn], Rademaker A, et al: Pain control for intrauterine device insertion: a randomized trial of 1 % lidocaine paracervical block. Contraception 86(6):704, 2012 fommers E, Blum GF, Gent TG, et al: Nexplanon, a radiopaque etonogestrel implat in combination with a next-generation applicator: 3-year results of a noncomparative multicenter trial. Am ] Obstet Gynecol 20 (5):388. el,n2012
Moraes LG, Marchi NM, Pitoli AC, et al: Assessment of the quality of cervical mucus among users of the levonorgestrel-releasing intrauterine system at diferent times of use. Eur J Contracept Reprod Health Care 7: 1, 2016
Moreau e, Trussell ], Gilbert F, et al: Oral contraceptive tolerance: does the type of pill matter? Obstet Gynecol 109: 1277, 2007
Moschos E, Twickler OM: Does the type of intrauterine device affect conspicuity on 20 and 3D ultrasound? AJR Am J Roentgenol 196(6): 1439, 2011
Murthy AS, Creinin MD, Harwood B, et al: Same-day initiation of the transdermal hormonal delivery system (contraceptive patch) versus traditional initiation methods. Contraception 72(5):333, 2005
Nahum GG, Kaunitz M, Rosen K, et al: Ovarian cysts: presence and persistence with use of a 13.5 mg levonorgestrel-releasing intrauterine system. Contraception 91(5):412, 2015
Nakajima ST, Pappadakis J, Archer OF: Body mass index does not afect the eicacy or bleeding proile during use of an ultra-low-dose combined oral contraceptive. Contraception 93(1):52, 2016
Nelson AL, Cwiak C: Combined oral contraceptives (COCs). In Hatcher A, Trussell J, Nelson AL, et al (eds): Contraceptive Technology, 20th ed. New York, Ardent Media, 2011
Ngai SW, Fan S, Li S, et al: A randomized trial to compare 24 h versus 12 h double dose regimen of levonorgestrel for emergency contraception. Hum Reprod 20:307, 2005
Ngo LL, Ward KK, Mody SK: Ketotolac for pain control with intrauterine device placement: a randomized controlled trial. Obstet Gynecol 126(1):29,n2015